SynthesisFrontiers in pharmacology2022

Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet's disease: A systematic review of controlled trials.

Xinwei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.